Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Jun 01 2023

· Issued by Caplin Point Laboratories Limited

Filed with NSE ·

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi".

View Attachment

6ix hasn’t read this filing yet.

Caplin Point Laboratories Limited on 6ix

Earlier from Caplin Point Laboratories

Later from Caplin Point Laboratories

All Caplin Point Laboratories news releases